PERIODONTAL DISEASES IN HIV-INFECTED PATIENTS: PREVALENCE AND PECULIARITIES OF CLINICAL MANIFESTATIONS DEPENDING ON ADHERENCE TO ANTIRETROVIRAL THERAPY

O S Gileva , V A Sadilova

Perm Medical Journal ›› 2013, Vol. 30 ›› Issue (2) : 34 -42.

PDF
Perm Medical Journal ›› 2013, Vol. 30 ›› Issue (2) :34 -42. DOI: 10.17816/pmj30234-42
Articles
research-article

PERIODONTAL DISEASES IN HIV-INFECTED PATIENTS: PREVALENCE AND PECULIARITIES OF CLINICAL MANIFESTATIONS DEPENDING ON ADHERENCE TO ANTIRETROVIRAL THERAPY

Author information +
History +
PDF

Abstract

Aim. To study the prevalence and clinical structure of periodontal diseases in HIV-infected patients depending on adherence to antiretroviral therapy (ART). Materials and methods. The study was based on the results of complex dental examination of 222 HIV-infected patients of “Perm Regional AIDS Center” over the period from 2009 to 2011. Results. Prevalence of classical inflammatory periodontal diseases in HIV-infected patients was 69,7% and that of specific HIV-associated periodontal diseases 27,0%. Patients who underwent antiretroviral therapy had reliably lower prevalence of HIV-associated periodontal diseases and less severe course of classical gingivitis and periodontitis. Conclusion. Dental status of HIV-infected patients is characterized by higher prevalence and intensity of periodontal diseases. Periodontal diseases in HIV-infected patients are characterized by polymorphism, they can be specific and nonspecific, conditioned by typical periodontopathogenic flora. Periodontologic status of HIV-infected patients not adherent to ART is compromised to a greater extent than in subjects receiving the corresponding antiviral therapy.

Keywords

HIV-associated periodontal diseases / linear gingival erythema / ulcerous-necrotic gingivitis / ulcerous-necrotic periodontitis / antiretroviral therapy

Cite this article

Download citation ▾
O S Gileva, V A Sadilova. PERIODONTAL DISEASES IN HIV-INFECTED PATIENTS: PREVALENCE AND PECULIARITIES OF CLINICAL MANIFESTATIONS DEPENDING ON ADHERENCE TO ANTIRETROVIRAL THERAPY. Perm Medical Journal, 2013, 30(2): 34-42 DOI:10.17816/pmj30234-42

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ВИЧ-инфекция в Пермском крае в 2012 г.: справка / Эпидемиологический отдел ГКУЗ ПКЦ СПИД и ИЗ. Пермь 2013.

[2]

Гилева О. С., Либик Т. В., Халилаева Е. В., Данилов К. В., Садилова В. А. Стоматологическое здоровье в критериях качества жизни. Медицинский вестник Башкортостана 2011; 3: 6–11.

[3]

Гилева О. С., Халилаева Е. В., Либик Т. В., Подгорный Р. В., Халявина И. Н. Многоступенчатая валидация международного опросника качества жизни «Профиль влияния стоматологического здоровья» OHIP-49-RU. Уральский медицинский журнал 2009; 8: 104–109.

[4]

Ефимов А. В. Особенности стоматологического статуса ВИЧ-инфицированных в латентной стадии и начальном периоде вторичных заболеваний: автореф. дис. … канд. мед. наук. Пермь 2005; 28.

[5]

Лечение ВИЧ-инфекции 2009 / под ред К. Хоффман, Ю. К. Рокшто. М.: Р. Валент 2012; 736.

[6]

Практическая терапевтическая стоматология / под ред. А. И. Николаева, Л. М. Цепова. М.: МЕДпресс-информ 2005; 489.

[7]

Coogan M., Greenspan J., Challocombe S. Oral lesions in infection with human immunodeficiency virus. Bull. Word Health Organ. 2005; 83: 1–16.

[8]

Efimov A., Gileva O., Khaliavina I., Goulyaeva Y., Khalilaeva E. Spectrum of oral manifestations in HIV-infected drug users on highly active antiretroviral therapy (HAART). Hordic-Baltic Oral Medicine meeting. Malmo 2007; 23.

[9]

Giacaman R. A., Asrani A. C., Gebhard K. H., Dietrich E. A., Vacharaksa A., Ross A., Herzberg M. C. Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology 2008; 5: 29.

[10]

Gileva O., Libik T., Khaliavina I., Goulyaeva Y., Khalilaeva E. Oral health-related quality of life in patients with non-specific ulcero-necrotic oral mucosal lesions. Oral Diseases 2008; 14: 24.

[11]

Gileva O. S., Libik T. V., Khalilaeva E. V., Bondarenko E. A. Oral mucosal diseases in HIV-infected Russians on HAART. The 6th World Workshop on Oral Health and Disease in AIDS. China 2009; 88.

[12]

Gileva O. S., Sazhina M. V., Gileva E. V., Efimov A. V., Scully C. Spectrum of oral manifestations of HIV/AIDS in the Perm region (Russia) and self-induced ulceronecrotic lingual lesions. Medicina Orale (Spain) 2004; 3 (9): 212–215.

[13]

Greenspan D., Greenspan J. Oral complications in HIV infection. Global HIV/AIDS medicine 2008; 215–225.

[14]

Huang C. B., Emerson K. F., Gonzalez O. A., Ebersole J. L. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells. Oral. Microbiol. Immunol. 2009; 24: 401–407.

[15]

Ryder M. I., Nittayananta W., Coogan M., Greenspan J., Greenspan D. Periodontal dissease in HIV/AIDS. Periodontology 2000 2012; 60: 78–97.

[16]

Vaughan J. P., Morrow R. H. Manual of epidemiology for district health management. Geneva: World Health Organization 1989.

RIGHTS & PERMISSIONS

Gileva O.S., Sadilova V.A.

AI Summary AI Mindmap
PDF

106

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/